Research ExplorerJournalsJ CLIN ONCOL Publications

J CLIN ONCOL - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

101 - 150 out of 201Page size: 50

Publications

  1. 2012

  2. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

    Lorch, A., Kleinhans, A., Kramar, A., Kollmannsberger, C. K., Hartmann, J. T., Bokemeyer, C., Rick, O. & Beyer, J., 10.03.2012, In: J CLIN ONCOL. 30, 8, p. 800-805 6 p., 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. The role of circumferential resection margin in esophageal cancer: Does it influence local recurrence and survival?

    Kutup, A., Ghadban, T., Vashist, Y. K., Bogoevski, D. & Izbicki, J. R., 02.2012, In: J CLIN ONCOL. 30, 4_suppl, p. 23

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab.

    Tejpar, S., Celik, I., Schlichting, M., Sartorius, U., Bokemeyer, C. & Eric, V. C., 2012, In: J CLIN ONCOL. 30, 29, p. 3570-3577 29.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.

    Cortes, J. E., Kim, D-W., Kantarjian, H. M., Brümmendorf, T., Dyagil, I., Griskevicius, L., Malhotra, H., Powell, C., Gogat, K., Countouriotis, A. M. & Gambacorti-Passerini, C., 2012, In: J CLIN ONCOL. 30, 28, p. 3486-3492 28.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.

    Lannering, B., Rutkowski, S., Doz, F., Pizer, B., Gustafsson, G., Navajas, A., Massimino, M., Reddingius, R., Benesch, M., Carrie, C., Taylor, R., Gandola, L., Björk-Eriksson, T., Giralt, J., Oldenburger, F., Pietsch, T., Figarella-Branger, D., Robson, K., Forni, M., Clifford, S. C., Warmuth-Metz, M., von Hoff, K., Faldum, A., Mosseri, V. & Kortmann, R., 2012, In: J CLIN ONCOL. 30, 26, p. 3187-3193 26.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?

    Schriefer, P., Steurer, S., Huland, H. & Graefen, M., 2012, In: J CLIN ONCOL. 30, 32, p. 341-344 32.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2011

  9. A randomized, double-blind, multicenter phase II AIO trial with gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with chemotherapy-naive advanced or metastatic biliary tract cancer: First safety and efficacy data

    Moehler, M. H., Schimanski, C. C., Kanzler, S., Woerns, M. A., Denzer, U., Kolligs, F. T., Ebert, M. P., Distelrath, A., Geissler, M., Zeuzem, S., Lammert, F., Lohse, A. W., Dollinger, M. M., Lindig, U., Duerr, E. M., Lubomierski, N., Zimmermann, S., Kabisch, M., Schadmann-Fischer, S., Galle, P. R. & German AIO, 20.05.2011, In: J CLIN ONCOL. 29, 15_suppl, p. 4077

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  10. Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.

    Sehouli, J., Stengel, D., Harter, P., Kurzeder, C., Belau, A., Bogenrieder, T., Markmann, S., Mahner, S., Mueller, L., Lorenz, R., Nugent, A., Wilke, J., Kuznik, A., Doering, G., Wischnik, A., Sommer, H., Meerpohl, H-G., Schroeder, W., Lichtenegger, W. & Oskay-Oezcelik, G., 10.01.2011, In: J CLIN ONCOL. 29, 2, p. 242-248 7 p., 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

    Press, M. F., Sauter, G., Buyse, M., Bernstein, L., Guzman, R., Santiago, A., Villalobos, I. E., Eiermann, W., Pienkowski, T., Martin, M., Robert, N., Crown, J., Bee, V., Taupin, H., Flom, K. J., Tabah-Fisch, I., Pauletti, G., Lindsay, M-A., Riva, A. & Slamon, D. J., 2011, In: J CLIN ONCOL. 29, 7, p. 859-867 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

    Lai, A., Kharbanda, S., Pope, W. B., Tran, A., Solis, O. E., Peale, F., Forrest, W. F., Pujara, K., Carrillo, J. A., Pandita, A., Ellingson, B. M., Bowers, C. W., Soriano, R. H., Schmidt, N-O., Mohan, S., Yong, W. H., Seshagiri, S., Modrusan, Z., Jiang, Z., Aldape, K. D., Mischel, P. S., Liau, L. M., Escovedo, C. J., Chen, W., Nghiemphu, P. L., James, C. D., Prados, M. D., Westphal, M., Lamszus, K., Cloughesy, T. & Phillips, H. S., 2011, In: J CLIN ONCOL. 29, 34, p. 4482-4490 34.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

    Remke, M., Hielscher, T., Korshunov, A., Northcott, P. A., Bender, S., Kool, M., Westermann, F., Benner, A., Cin, H., Ryzhova, M., Sturm, D., Witt, H., Haag, D., Toedt, G., Wittmann, A., Schöttler, A., von Bueren, A., André, O., Rutkowski, S., Rutkowski, S., Scheurlen, W., Kulozik, A. E., Taylor, M. D., Lichter, P. & Pfister, S. M., 2011, In: J CLIN ONCOL. 29, 29, p. 3852-3861 29.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

    Thol, F., Damm, F., Lüdeking, A., Winschel, C., Wagner, K., Morgan, M., Yun, H., Göhring, G., Schlegelberger, B., Hoelzer, D., Lübbert, M., Kanz, L., Fiedler, W., Kirchner, H., Heil, G., Krauter, J., Ganser, A. & Heuser, M., 2011, In: J CLIN ONCOL. 29, 21, p. 2889-2896 21.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab.

    Rüssel, J., Stein, A., Behrmann, C., Hauptmann, S., Krummenerl, P., Schmoll, H-J. & Arnold, D., 2011, In: J CLIN ONCOL. 29, 22, p. 644-646 22.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

    Peck, A. R., Witkiewicz, A. K., Liu, C., Stringer, G. A., Klimowicz, A. C., Pequignot, E., Freydin, B., Tran, T. H., Yang, N., Rosenberg, A. L., Hooke, J. A., Kovatich, A. J., Nevalainen, M. T., Shriver, C. D., Hyslop, T., Sauter, G., Rimm, D. L., Magliocco, A. M. & Rui, H., 2011, In: J CLIN ONCOL. 29, 18, p. 2448-2458 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Malignant transformation of a serous borderline tumor and early metastasis of associated low-grade serous carcinoma detected on screening mammography.

    Grimm, D., Trillsch, F., Regier, M., Choschzick, M., Kommoss, F., Hermsteiner, M., Töllner, T., Mattner, U. M., Jänicke, F. & Mahner, S., 2011, In: J CLIN ONCOL. 29, 30, p. 763-765 30.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens.

    Valero, V., Forbes, J., Pegram, M. D., Pienkowski, T., Eiermann, W., von Minckwitz, G., Roche, H., Martin, M., Crown, J., Mackey, J. R., Fumoleau, P., Rolski, J., Mrsic-Krmpotic, Z., Jagiello-Gruszfeld, A., Riva, A., Buyse, M., Taupin, H., Sauter, G., Press, M. F. & Slamon, D. J., 2011, In: J CLIN ONCOL. 29, 2, p. 149-156 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

    Untch, M., Fasching, P. A., Konecny, G. E., Hasmüller, S., Lebeau, A., Kreienberg, R., Camara, O., Müller, V., Andreas, D. B., Kühn, T., Stickeler, E., Harbeck, N., Höss, C., Kahlert, S., Beck, T., Fett, W., Mehta, K. M., von Minckwitz, G. & Loibl, S., 2011, In: J CLIN ONCOL. 29, 25, p. 3351-3357 25.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

    Eiermann, W., Pienkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, A., Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M., Sauter, G., Lindsay, M-A., Riva, A., Buyse, M., Drevot, P., Taupin, H. & Mackey, J. R., 2011, In: J CLIN ONCOL. 29, 29, p. 3877-3884 29.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

    Barbui, T., Barosi, G., Birgegard, G., Cervantes, F., Finazzi, G., Griesshammer, M., Harrison, C., Hasselbalch, H. C., Hehlmann, R., Hoffman, R., Kiladjian, J-J., Kröger, N., Mesa, R., McMullin, M. F., Pardanani, A., Passamonti, F., Vannucchi, A. M., Reiter, A., Silver, R. T., Verstovsek, S., Tefferi, A. & LeukemiaNet, E., 2011, In: J CLIN ONCOL. 29, 6, p. 761-770 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.

    Damm, F., Oberacker, T., Thol, F., Surdziel, E., Wagner, K., Chaturvedi, A., Morgan, M., Bomm, K., Göhring, G., Lübbert, M., Kanz, L., Fiedler, W., Schlegelberger, B., Heil, G., Schlenk, R. F., Döhner, K., Döhner, H., Krauter, J., Ganser, A. & Heuser, M., 2011, In: J CLIN ONCOL. 29, 6, p. 682-689 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Serum enterolactone and prognosis of postmenopausal breast cancer.

    Buck, K., Vrieling, A., Zaineddin, A. K., Becker, S., Hüsing, A., Kaaks, R., Linseisen, J., Flesch-Janys, D. & Chang-Claude, J., 2011, In: J CLIN ONCOL. 29, 28, p. 3730-3738 28.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.

    Hehlmann, R., Lauseker, M., Jung-Munkwitz, S., Leitner, A., Müller, M. C., Pletsch, N., Proetel, U., Haferlach, C., Schlegelberger, B., Balleisen, L., Hänel, M., Pfirrmann, M., Krause, S. W., Nerl, C., Pralle, H., Gratwohl, A., Hossfeld, D., Hasford, J., Hochhaus, A. & Saussele, S., 2011, In: J CLIN ONCOL. 29, 12, p. 1634-1642 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2010

  26. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.

    Korshunov, A., Remke, M., Werft, W., Benner, A., Ryzhova, M., Witt, H., Sturm, D., Wittmann, A., Schöttler, A., Felsberg, J., Reifenberger, G., Rutkowski, S., Scheurlen, W., Kulozik, A. E., von Deimling, A., Lichter, P. & Pfister, S. M., 2010, In: J CLIN ONCOL. 28, 18, p. 3054-3060 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia.

    Lim, Z., Brand, R., Martino, R., van Biezen, A., Finke, J., Bacigalupo, A., Beelen, D., Devergie, A., Alessandrino, E., Willemze, R., Ruutu, T., Boogaerts, M., Falda, M., Jouet, J-P., Niederwieser, D., Kröger, N., Mufti, G. J., Witte, D. & Theo, M., 2010, In: J CLIN ONCOL. 28, 3, p. 405-411 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.

    Casper, J., Wolff, D., Knauf, W., Blau, I. W., Ruutu, T., Volin, L., Wandt, H., Schäfer-Eckart, K., Holowiecki, J., Giebel, S., Aschan, J., Zander, A. R., Kröger, N., Hilgendorf, I., Baumgart, J., Mylius, H. A., Pichlmeier, U. & Freund, M., 2010, In: J CLIN ONCOL. 28, 20, p. 3344-3351 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

    Aricò, M., Schrappe, M., Hunger, S. P., Carroll, W. L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., Horibe, K., Benoit, Y., Pieters, R., Escherich, G., Silverman, L. B., Pui, C-H. & Valsecchi, M. G., 2010, In: J CLIN ONCOL. 28, 31, p. 4755-4761 31.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. First-line trastuzumab plus epirubicin and cyclophosphamide therapy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: cardiac safety and efficacy data from the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) trial.

    Untch, M., Muscholl, M., Tjulandin, S., Jonat, W., Meerpohl, H-G., Lichinitser, M., Manikhas, A. G., Coumbos, A., Kreienberg, R., Andreas, D. B., Harbeck, N., Jackisch, C., Müller, V., Pauschinger, M., Thomssen, C., Lehle, M., Catalani, O. & Lück, H-J., 2010, In: J CLIN ONCOL. 28, 9, p. 1473-1480 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

    Wagner, K., Damm, F., Göhring, G., Görlich, K., Heuser, M., Schäfer, I., Ottmann, O., Lübbert, M., Heit, W., Kanz, L., Schlimok, G., Raghavachar, A. A., Fiedler, W., Kirchner, H. H., Brugger, W., Zucknick, M., Schlegelberger, B., Heil, G., Ganser, A. & Krauter, J., 2010, In: J CLIN ONCOL. 28, 14, p. 2356-2364 14.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.

    Lokhorst, H., Einsele, H., Vesole, D., Bruno, B., Jesus, S. M., Pérez-Simon, J. A., Kröger, N., Moreau, P., Gahrton, G., Gasparetto, C., Giralt, S. & Bensinger, W., 2010, In: J CLIN ONCOL. 28, 29, p. 4521-4530 29.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

    Tallen, G., Ratei, R., Mann, G., Kaspers, G., Niggli, F., Karachunsky, A., Ebell, W., Escherich, G., Schrappe, M., Klingebiel, T., Fengler, R., Henze, G. & von Stackelberg, A., 2010, In: J CLIN ONCOL. 28, 14, p. 2339-2347 14.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression.

    Rades, D., Huttenlocher, S., Dunst, J., Bajrovic, A., Karstens, J. H., Rudat, V. & Schild, S. E., 2010, In: J CLIN ONCOL. 28, 22, p. 3597-3604 22.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.

    Meinhardt, A., Burkhardt, B., Zimmermann, M., Borkhardt, A., Kontny, U., Klingebiel, T., Berthold, F., Janka-Schaub, G., Klein, C., Kabickova, E., Klapper, W., Attarbaschi, A., Schrappe, M., Reiter, A. & Group, B-F-M., 2010, In: J CLIN ONCOL. 28, 19, p. 3115-3121 19.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma.

    Lughezzani, G., Sun, M., Budäus, L., Thuret, R., Perrotte, P. & Karakiewicz, P. I., 2010, In: J CLIN ONCOL. 28, 18, p. 299-301 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.

    Lebeau, A., Turzynski, A., Braun, S., Behrhof, W., Fleige, B., Schmitt, W. D., Grob, T., Burkhardt, L., Hölzel, D., Jackisch, C., Thomssen, C., Müller, V. & Untch, M., 2010, In: J CLIN ONCOL. 28, 20, p. 3264-3270 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.

    Dimopoulos, M. A., Terpos, E., Chanan-Khan, A., Leung, N., Ludwig, H., Jagannath, S., Niesvizky, R., Giralt, S., Fermand, J-P., Bladé, J., Comenzo, R. L., Sezer, O., Palumbo, A., Harousseau, J-L., Richardson, P. G., Barlogie, B., Anderson, K. C., Sonneveld, P., Tosi, P., Cavo, M., Rajkumar, S. V., Durie, B. G. M. & Jésus, S. M., 2010, In: J CLIN ONCOL. 28, 33, p. 4976-4984 33.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.

    Rutkowski, S., von Hoff, K., Emser, A., Zwiener, I., Pietsch, T., Figarella-Branger, D., Giangaspero, F., Ellison, D. W., Garre, M-L., Biassoni, V., Grundy, R. G., Finlay, J. L., Dhall, G., Raquin, M-A. & Grill, J., 2010, In: J CLIN ONCOL. 28, 33, p. 4961-4968 33.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.

    Pfaff, E., Remke, M., Sturm, D., Benner, A., Witt, H., Till, M., von Bueren, A., André, O., Wittmann, A., Schöttler, A., Jorch, N., Graf, N., Kulozik, A. E., Witt, O., Scheurlen, W., Rutkowski, S., Rutkowski, S., Taylor, M. D., Tabori, U., Lichter, P., Korshunov, A. & Pfister, S. M., 2010, In: J CLIN ONCOL. 28, 35, p. 5188-5196 35.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. 2009

  42. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies

    Steinbach, S., Hummel, T., Böhner, C., Berktold, S., Hundt, W., Kriner, M., Heinrich, P., Sommer, H., Hanusch, C., Prechtl, A., Schmidt, B., Bauerfeind, I., Seck, K., Jacobs, V. R., Schmalfeldt, B. & Harbeck, N., 10.04.2009, In: J CLIN ONCOL. 27, 11, p. 1899-905 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Bone marrow aspiration for disseminated tumor cell detection: a must-have test or is the jury still out?

    Scher, H. I. & Pantel, K., 2009, In: J CLIN ONCOL. 27, 10, p. 1531-1533 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.

    Dantonello, T. M., Int-Veen, C., Harms, D., Leuschner, I., Schmidt, B. F., Herbst, M., Juergens, H., Scheel-Walter, H-G., Bielack, S. S., Klingebiel, T., Dickerhoff, R., Kirsch, S., Brecht, I., Schmelzle, R., Greulich, M., Gadner, H., Greiner, J., Marky, I., Treuner, J. & Koscielniak, E., 2009, In: J CLIN ONCOL. 27, 9, p. 1446-1455 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.

    Langenberg, M. H. G., Herpen, V., Carla, M. L., Johann, D. B., Schellens, J. H. M., Unger, C., Hoekman, K., Fiedler, W., Fiedler, W., Drevs, J., Florence, L. M., Fielding, A., Robertson, J. & Voest, E. E., 2009, In: J CLIN ONCOL. 27, 36, p. 6152-6159 36.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.

    Bokemeyer, C., Bondarenko, I., Makhson, A., Hartmann, J. T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., Loos, A. H., Zubel, A. & Koralewski, P., 2009, In: J CLIN ONCOL. 27, 5, p. 663-671 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.

    Sauter, G., Lee, J., Bartlett, J. M. S., Slamon, D. J. & Press, M. F., 2009, In: J CLIN ONCOL. 27, 8, p. 1323-1333 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

    Untch, M., Möbus, V., Kuhn, W., Muck, B. R., Thomssen, C., Bauerfeind, I., Harbeck, N., Werner, C., Lebeau, A., Schneeweiss, A., Kahlert, S., von Koch, F., Petry, K. U., Wallwiener, D., Kreienberg, R., Albert, U-S., Lück, H-J., Hinke, A., Jänicke, F. & Konecny, G. E., 2009, In: J CLIN ONCOL. 27, 18, p. 2938-2945 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.

    Honecker, F., Wermann, H., Mayer, F., Gillis, A. J. M., Stoop, H., Gurp, V., Oechsle, K., Oechsle, K., Steyerberg, E., Hartmann, J. T., Dinjens, W. N. M., Bokemeyer, C., Bokemeyer, C. & Looijenga, L. H. J., 2009, In: J CLIN ONCOL. 27, 13, p. 2129-2136 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.

    Weller, M., Felsberg, J., Hartmann, C., Berger, H., Steinbach, J. P., Schramm, J., Westphal, M., Schackert, G., Simon, M., Tonn, J. C., Heese, O., Krex, D., Nikkhah, G., Pietsch, T., Wiestler, O., Reifenberger, G., von Deimling, A. & Loeffler, M., 2009, In: J CLIN ONCOL. 27, 34, p. 5743-5750 34.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

    Schwarz-Dose, J., Untch, M., Tiling, R., Sassen, S., Mahner, S., Kahlert, S., Harbeck, N., Lebeau, A., Brenner, W., Schwaiger, M., Jänicke, F. & Avril, N., 2009, In: J CLIN ONCOL. 27, 4, p. 535-541 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.

    Goekkurt, E., Al-Batran, S-E., Hartmann, J. T., Mogck, U., Schuch, G., Kramer, M., Jaeger, E., Bokemeyer, C., Ehninger, G. & Stoehlmacher, J., 2009, In: J CLIN ONCOL. 27, 17, p. 2863-2873 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

    Rinke, A., Müller, H-H., Schade-Brittinger, C., Klose, K-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U-F., Bläker, M., Harder, J., Arnold, C., Gress, T. & Arnold, R., 2009, In: J CLIN ONCOL. 27, 28, p. 4656-4663 28.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

    Bader, P., Kreyenberg, H., Henze, G. H. R., Eckert, C., Reising, M., Willasch, A., Barth, A., Borkhardt, A., Peters, C., Handgretinger, R., Sykora, K-W., Holter, W., Kabisch, H., Klingebiel, T. & von Stackelberg, A., 2009, In: J CLIN ONCOL. 27, 3, p. 377-384 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 Next